NO800230L - Fremgangsmaate ved fremstilling av kinazolinderivater - Google Patents
Fremgangsmaate ved fremstilling av kinazolinderivaterInfo
- Publication number
- NO800230L NO800230L NO800230A NO800230A NO800230L NO 800230 L NO800230 L NO 800230L NO 800230 A NO800230 A NO 800230A NO 800230 A NO800230 A NO 800230A NO 800230 L NO800230 L NO 800230L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- phenyl
- compound
- formula
- piperidine
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 18
- 238000000034 method Methods 0.000 title claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 27
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- 239000000460 chlorine Substances 0.000 claims description 6
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 claims description 3
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- 238000005984 hydrogenation reaction Methods 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- 231100000252 nontoxic Toxicity 0.000 claims description 2
- 230000003000 nontoxic effect Effects 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 45
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 44
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 39
- 239000000243 solution Substances 0.000 description 34
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 24
- 239000002904 solvent Substances 0.000 description 24
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- 238000010992 reflux Methods 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000000725 suspension Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 11
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 10
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 10
- 239000002026 chloroform extract Substances 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 229910052938 sodium sulfate Inorganic materials 0.000 description 9
- 235000011152 sodium sulphate Nutrition 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- 239000007787 solid Substances 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 5
- 235000019341 magnesium sulphate Nutrition 0.000 description 5
- 150000003891 oxalate salts Chemical class 0.000 description 5
- VUOXOBUGCOTNBV-UHFFFAOYSA-N 1-[4-(2-hydroxy-1-phenylethoxy)piperidin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCC1OC(CO)C1=CC=CC=C1 VUOXOBUGCOTNBV-UHFFFAOYSA-N 0.000 description 4
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 239000002480 mineral oil Substances 0.000 description 4
- 235000010446 mineral oil Nutrition 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 4
- HWIIAAVGRHKSOJ-UHFFFAOYSA-N 2-chloro-6,7-dimethoxyquinazolin-4-amine Chemical compound ClC1=NC(N)=C2C=C(OC)C(OC)=CC2=N1 HWIIAAVGRHKSOJ-UHFFFAOYSA-N 0.000 description 3
- QZYFOOHHZWNYEW-UHFFFAOYSA-N 2-phenyl-1-piperidin-4-yloxypropan-2-ol Chemical compound C=1C=CC=CC=1C(O)(C)COC1CCNCC1 QZYFOOHHZWNYEW-UHFFFAOYSA-N 0.000 description 3
- JHHLUDVQZWAIOV-UHFFFAOYSA-N 4-(2-phenoxy-1-phenylethoxy)piperidine Chemical compound C1CNCCC1OC(C=1C=CC=CC=1)COC1=CC=CC=C1 JHHLUDVQZWAIOV-UHFFFAOYSA-N 0.000 description 3
- RTMVEYKTNQUBRW-UHFFFAOYSA-N 4-amino-2-[4-(2-ethoxy-1-phenylethoxy)piperidin-1-yl]-7-methoxyquinazolin-6-ol Chemical compound NC1=NC(=NC2=CC(=C(C=C12)O)OC)N1CCC(CC1)OC(COCC)C1=CC=CC=C1 RTMVEYKTNQUBRW-UHFFFAOYSA-N 0.000 description 3
- -1 4-amino-2-[4-(2-ethoxy-1-phenylethoxy)piperidino]-6-hydroxy-7-methoxyquinazoline hydrochloride Chemical compound 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000001030 gas--liquid chromatography Methods 0.000 description 3
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 3
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 229940095064 tartrate Drugs 0.000 description 3
- KZPIFQYDCVCSDS-UHFFFAOYSA-N 1-(4-hydroxypiperidin-1-yl)ethanone Chemical compound CC(=O)N1CCC(O)CC1 KZPIFQYDCVCSDS-UHFFFAOYSA-N 0.000 description 2
- XBFLETFUQPUNHF-UHFFFAOYSA-N 1-[4-[2-(2-hydroxyphenyl)ethoxy]piperidin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCC1OCCC1=CC=CC=C1O XBFLETFUQPUNHF-UHFFFAOYSA-N 0.000 description 2
- BEXWWKGYRANPGQ-UHFFFAOYSA-N 2-(1-acetylpiperidin-4-yl)oxy-2-phenylacetic acid Chemical compound C1CN(C(=O)C)CCC1OC(C(O)=O)C1=CC=CC=C1 BEXWWKGYRANPGQ-UHFFFAOYSA-N 0.000 description 2
- DNKXLUPNIXJUED-UHFFFAOYSA-N 4-(2-ethoxy-1-phenylethoxy)piperidine Chemical compound C=1C=CC=CC=1C(COCC)OC1CCNCC1 DNKXLUPNIXJUED-UHFFFAOYSA-N 0.000 description 2
- UZESJHADWGWPKB-UHFFFAOYSA-N 4-(2-ethoxy-2-phenylpropoxy)piperidine Chemical compound C=1C=CC=CC=1C(C)(OCC)COC1CCNCC1 UZESJHADWGWPKB-UHFFFAOYSA-N 0.000 description 2
- GDHADTLPFJMCOI-UHFFFAOYSA-N 6-(cyclopropylmethoxy)-2-[4-(2-ethoxy-1-phenylethoxy)piperidin-1-yl]-7-methoxyquinazolin-4-amine Chemical compound NC1=NC(=NC2=CC(=C(C=C12)OCC1CC1)OC)N1CCC(CC1)OC(COCC)C1=CC=CC=C1 GDHADTLPFJMCOI-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 239000012448 Lithium borohydride Substances 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- DULCUDSUACXJJC-UHFFFAOYSA-N benzeneacetic acid ethyl ester Natural products CCOC(=O)CC1=CC=CC=C1 DULCUDSUACXJJC-UHFFFAOYSA-N 0.000 description 2
- AEILLAXRDHDKDY-UHFFFAOYSA-N bromomethylcyclopropane Chemical compound BrCC1CC1 AEILLAXRDHDKDY-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 150000002440 hydroxy compounds Chemical class 0.000 description 2
- BRMYZIKAHFEUFJ-UHFFFAOYSA-L mercury diacetate Chemical compound CC(=O)O[Hg]OC(C)=O BRMYZIKAHFEUFJ-UHFFFAOYSA-L 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- XINQFOMFQFGGCQ-UHFFFAOYSA-L (2-dodecoxy-2-oxoethyl)-[6-[(2-dodecoxy-2-oxoethyl)-dimethylazaniumyl]hexyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCCCOC(=O)C[N+](C)(C)CCCCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCC XINQFOMFQFGGCQ-UHFFFAOYSA-L 0.000 description 1
- MBCMIJDQQZZMQE-UHFFFAOYSA-N 1-[4-(2-hydroxy-2-phenylpropoxy)piperidin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCC1OCC(C)(O)C1=CC=CC=C1 MBCMIJDQQZZMQE-UHFFFAOYSA-N 0.000 description 1
- DCFIFQMXQJMGPV-UHFFFAOYSA-N 1-[4-[2-(2-ethoxyphenyl)ethoxy]piperidin-1-yl]ethanone Chemical compound CCOC1=CC=CC=C1CCOC1CCN(C(C)=O)CC1 DCFIFQMXQJMGPV-UHFFFAOYSA-N 0.000 description 1
- WPNFPRWHXVVLKV-UHFFFAOYSA-N 2-(2-piperidin-4-yloxyethyl)phenol Chemical compound OC1=CC=CC=C1CCOC1CCNCC1 WPNFPRWHXVVLKV-UHFFFAOYSA-N 0.000 description 1
- KNWAOWNYXRUCNP-UHFFFAOYSA-N 2-(2-piperidin-4-yloxyethyl)phenol;hydrochloride Chemical compound Cl.OC1=CC=CC=C1CCOC1CCNCC1 KNWAOWNYXRUCNP-UHFFFAOYSA-N 0.000 description 1
- GSGULLVGUFGOCN-UHFFFAOYSA-N 2-[4-(2-ethoxy-1-phenylethoxy)piperidin-1-yl]-6,7-dimethoxyquinazolin-4-amine Chemical compound C1CN(C=2N=C3C=C(OC)C(OC)=CC3=C(N)N=2)CCC1OC(COCC)C1=CC=CC=C1 GSGULLVGUFGOCN-UHFFFAOYSA-N 0.000 description 1
- WAKFRZBXTKUFIW-UHFFFAOYSA-N 2-bromo-2-phenylacetic acid Chemical compound OC(=O)C(Br)C1=CC=CC=C1 WAKFRZBXTKUFIW-UHFFFAOYSA-N 0.000 description 1
- VULUOYHJUMCHSH-UHFFFAOYSA-N 2-chloro-7-methoxy-6-phenylmethoxyquinazolin-4-amine Chemical compound COC1=CC2=NC(Cl)=NC(N)=C2C=C1OCC1=CC=CC=C1 VULUOYHJUMCHSH-UHFFFAOYSA-N 0.000 description 1
- MDGLKMXWHKGENE-UHFFFAOYSA-N 2-piperidin-1-ylquinazolin-4-amine Chemical class N=1C2=CC=CC=C2C(N)=NC=1N1CCCCC1 MDGLKMXWHKGENE-UHFFFAOYSA-N 0.000 description 1
- RMMHOFFPGKSRDI-UHFFFAOYSA-N 3-bromoprop-1-en-2-ylbenzene Chemical compound BrCC(=C)C1=CC=CC=C1 RMMHOFFPGKSRDI-UHFFFAOYSA-N 0.000 description 1
- IBIZRLDTGNZMGO-UHFFFAOYSA-N 4-[2-(2-ethoxyphenyl)ethoxy]piperidine Chemical compound CCOC1=CC=CC=C1CCOC1CCNCC1 IBIZRLDTGNZMGO-UHFFFAOYSA-N 0.000 description 1
- OHCMRDCUBBBJJO-UHFFFAOYSA-N 4-[2-(2-ethoxyphenyl)ethoxy]piperidine;oxalic acid Chemical compound OC(=O)C(O)=O.CCOC1=CC=CC=C1CCOC1CCNCC1 OHCMRDCUBBBJJO-UHFFFAOYSA-N 0.000 description 1
- MGFBKDPJZBACKV-UHFFFAOYSA-N 6-ethoxy-2-[4-(2-ethoxy-1-phenylethoxy)piperidin-1-yl]-7-methoxyquinazolin-4-amine hydroiodide Chemical compound I.NC1=NC(=NC2=CC(=C(C=C12)OCC)OC)N1CCC(CC1)OC(COCC)C1=CC=CC=C1 MGFBKDPJZBACKV-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- CDPIELCYCWDBOT-UHFFFAOYSA-N C(C)(=O)C1CNCCC1O Chemical compound C(C)(=O)C1CNCCC1O CDPIELCYCWDBOT-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- SCENUOUAYLAIEO-UHFFFAOYSA-N Cl.NC1=NC(=NC2=CC(=C(C=C12)OCC1=CC=CC=C1)OC)N1CCC(CC1)OC(COCC)C1=CC=CC=C1 Chemical compound Cl.NC1=NC(=NC2=CC(=C(C=C12)OCC1=CC=CC=C1)OC)N1CCC(CC1)OC(COCC)C1=CC=CC=C1 SCENUOUAYLAIEO-UHFFFAOYSA-N 0.000 description 1
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- 241000786363 Rhampholeon spectrum Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- AWMVMTVKBNGEAK-UHFFFAOYSA-N Styrene oxide Chemical compound C1OC1C1=CC=CC=C1 AWMVMTVKBNGEAK-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M bisulphate group Chemical group S([O-])(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- ZIDNDHOWBISBIO-UHFFFAOYSA-N quinazoline;hydrate;hydrochloride Chemical compound O.Cl.N1=CN=CC2=CC=CC=C21 ZIDNDHOWBISBIO-UHFFFAOYSA-N 0.000 description 1
- VBUBADWLHFZFDK-UHFFFAOYSA-N quinazoline;hydrochloride Chemical compound Cl.N1=CN=CC2=CC=CC=C21 VBUBADWLHFZFDK-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000005415 substituted alkoxy group Chemical group 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical class CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7903398 | 1979-01-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO800230L true NO800230L (no) | 1980-08-01 |
Family
ID=10502852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO800230A NO800230L (no) | 1979-01-31 | 1980-01-30 | Fremgangsmaate ved fremstilling av kinazolinderivater |
Country Status (28)
| Country | Link |
|---|---|
| JP (1) | JPS55104278A (it) |
| AR (1) | AR222208A1 (it) |
| AT (1) | AT373595B (it) |
| BE (1) | BE881448A (it) |
| CA (1) | CA1131636A (it) |
| CS (1) | CS231970B2 (it) |
| DD (1) | DD148720A5 (it) |
| DE (1) | DE3003323A1 (it) |
| DK (1) | DK540879A (it) |
| ES (1) | ES488129A0 (it) |
| FI (1) | FI63936C (it) |
| FR (1) | FR2447919A1 (it) |
| GR (1) | GR73626B (it) |
| HU (1) | HU184233B (it) |
| IE (1) | IE800178L (it) |
| IL (1) | IL59252A (it) |
| IT (1) | IT1149902B (it) |
| LU (1) | LU82115A1 (it) |
| NL (1) | NL8000571A (it) |
| NO (1) | NO800230L (it) |
| NZ (1) | NZ192744A (it) |
| PH (1) | PH15436A (it) |
| PL (1) | PL121890B1 (it) |
| PT (1) | PT70749A (it) |
| SE (1) | SE8000699L (it) |
| SU (1) | SU895291A3 (it) |
| YU (1) | YU22980A (it) |
| ZA (1) | ZA80557B (it) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2483920A1 (fr) * | 1980-06-09 | 1981-12-11 | Synthelabo | Nouveaux derives de quinazoline, leur procede de preparation et leur application en therapeutique |
| ES515338A0 (es) * | 1981-09-09 | 1983-11-01 | Orion Yhtymae Oy | "metodo para la preparacion de piperidinilquinazolidinas substituidas". |
| US5280032A (en) * | 1989-02-14 | 1994-01-18 | Toyama Chemical Co., Ltd. | 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
| WO2013070852A2 (en) * | 2011-11-08 | 2013-05-16 | Emory University | Compounds and compositions used to epigenetically transform cells and methods related thereto |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1088068A (en) * | 1977-11-16 | 1980-10-21 | Simon F. Campbell | Piperidino-quinazolines |
| GB2021108B (en) * | 1978-05-18 | 1982-07-21 | Pfizer Ltd | 6,7 - di - 4 - amino - 2 - quinazolines |
-
1979
- 1979-01-30 IE IE800178A patent/IE800178L/xx unknown
- 1979-12-18 DK DK540879A patent/DK540879A/da not_active Application Discontinuation
-
1980
- 1980-01-28 PH PH23559A patent/PH15436A/en unknown
- 1980-01-29 IL IL59252A patent/IL59252A/xx unknown
- 1980-01-29 AT AT0046980A patent/AT373595B/de not_active IP Right Cessation
- 1980-01-29 YU YU00229/80A patent/YU22980A/xx unknown
- 1980-01-29 FI FI800252A patent/FI63936C/fi not_active IP Right Cessation
- 1980-01-29 CS CS80607A patent/CS231970B2/cs unknown
- 1980-01-29 IT IT19537/80A patent/IT1149902B/it active
- 1980-01-29 SE SE8000699A patent/SE8000699L/xx not_active Application Discontinuation
- 1980-01-29 NZ NZ192744A patent/NZ192744A/en unknown
- 1980-01-30 AR AR279793A patent/AR222208A1/es active
- 1980-01-30 HU HU80202A patent/HU184233B/hu unknown
- 1980-01-30 JP JP990580A patent/JPS55104278A/ja active Granted
- 1980-01-30 DE DE19803003323 patent/DE3003323A1/de not_active Ceased
- 1980-01-30 SU SU802877159A patent/SU895291A3/ru active
- 1980-01-30 BE BE0/199187A patent/BE881448A/fr not_active IP Right Cessation
- 1980-01-30 FR FR8002012A patent/FR2447919A1/fr active Granted
- 1980-01-30 NL NL8000571A patent/NL8000571A/nl not_active Application Discontinuation
- 1980-01-30 NO NO800230A patent/NO800230L/no unknown
- 1980-01-30 CA CA344,714A patent/CA1131636A/en not_active Expired
- 1980-01-30 PL PL1980221683A patent/PL121890B1/pl unknown
- 1980-01-30 PT PT70749A patent/PT70749A/pt unknown
- 1980-01-30 ZA ZA00800557A patent/ZA80557B/xx unknown
- 1980-01-31 DD DD80218769A patent/DD148720A5/de unknown
- 1980-01-31 ES ES488129A patent/ES488129A0/es active Granted
- 1980-01-31 LU LU82115A patent/LU82115A1/fr unknown
- 1980-02-11 GR GR61081A patent/GR73626B/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO177590B (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive cykliske aminforbindelser | |
| EP0974583B1 (en) | Phenylpiperidine derivatives | |
| KR20070026300A (ko) | 펙소페나딘 다형 및 그 제조방법 | |
| HU222726B1 (hu) | Piperidinszármazékok, eljárás elżállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
| NO146359B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater | |
| JPH06500076A (ja) | ピペリジン化合物、その合成およびその使用方法 | |
| DK166584B1 (da) | Substituerede 4-benzyl-1h-imidazoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende dem | |
| NO800230L (no) | Fremgangsmaate ved fremstilling av kinazolinderivater | |
| NO773300L (no) | Fremgangsmaate for fremstilling av nye eddiksyrederivater | |
| NO136713B (it) | ||
| EP1440075A1 (fr) | Nouveaux derives amides heteroaromatiques de 3beta-amino azabicyclooctane, leur procede de preparation et leurs applications en therapeutique | |
| GB2171997A (en) | 4-Amino-6,7-dimethoxy-2-Piperazin-1-ylquinazoline derivatives | |
| NO174669B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiopyranylaminer | |
| HU195964B (en) | Process for preparing octahydro-indolizine derivatives and pharmaceutical compositions containing such compounds as active ingredients | |
| US3992546A (en) | 4-Piperidinobutyrophenones as neuroleptics | |
| US4237138A (en) | Antihypertensive 4-amino-2-[4-(substituted-alkoxy)piperidino)]quinazolines | |
| DE1933599A1 (de) | Chinolinderivate | |
| SU442600A1 (ru) | Способ получени производных 4нбензо-(4,5)-циклогепта-/1,2- /-тиофена | |
| US3869461A (en) | Intermediates for quinine, quinidine and derivatives thereof | |
| US3857846A (en) | {60 -{8 1-benzoyl-3r-alkyl-4(r)-piperidylmethyl{9 {62 -oxo-{62 (6,7 substituted-4 quinolyl)propionic acid and racemates | |
| GB2041373A (en) | Quinazoline antihypertensives | |
| US3828053A (en) | Lower-alkyl-beta-oxo-4-piperidine-n-benzoylpropionates | |
| KR880002000B1 (ko) | 헥사하이드로나프트[1,2-b]-1,4-옥사진의 제조방법 | |
| KR820001339B1 (ko) | 4-아미노-2-피페리디노-퀴나졸린 유도체의 제조방법 | |
| NO121342B (it) |